Solventum

American health care company spun off from 3M in 2024

SOLV NYSE ISIN US83444M1018 SEC CIK 1964738 LEI 254900I70403OSGY4M28
Follow Solventum Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $1.9B −7% vs same quarter last year
Net income −$12M −100.9% vs same quarter last year
EPS, diluted −$0.07 −101% vs same quarter last year
Operating cash flow $177M +132.9% vs same quarter last year
Revenue by quarter
$2.1B
$2.1B
$2.2B
$2.1B
$2B
$2B
$2.2B
$1.9B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
$0$2.5B$5B$7.5B$10BFY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$8.3B$1.6B
FY24$8.3B$479M
FY23$8.2B$1.3B
FY22$8.1B$1.3B
FY21--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%20%40%60%FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2553.5%26.2%18.7%
FY2455.6%12.6%5.8%
FY2357.3%20.6%16.4%
FY2257.7%20.8%16.5%
FY21---
Free cash flowOperating cash flow minus capital expenditure
−$500M$0$500M$1B$1.5B$2BFY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$10M
FY24$805M
FY23$1.6B
FY22$1.4B
FY21-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Solventum
  • Healthcare median
−100%−75%−50%−25%0%25%FY21FY22FY23FY24FY25
Show the numbers
YearSolventumHealthcare median
FY2518.7%−30.6%
FY245.8%−47%
FY2316.4%−58%
FY2216.5%−80.4%
FY21-−71.9%